ERBB2 and breast carcinoma: In the present study, we analyzed whether a GnRH-II antagonist induces apoptosis in estrogen receptor/progesterone receptor-positive MCF-7 human breast cancer cells, which have a normal expression of HER2-neu and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo.